Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture & Organoids

Michael Churchill's Biography

Michael Churchill, Lead Scientist, SEngine Precision Medicine

I build new tools and novel platforms to innovate and optimize high throughput screening technologies. I began working at SEngine Precision Medicine in the Fall of 2016 and have since applied my knowledge and expertise of high-throughput and high-content screen design to maintain and innovate the SEngine clinical platform and to ensure that SEngine remains an industry pioneer during an era of unprecedented innovation of healthcare and biotechnology. On my watch, I will assure that SEngine and the PARIS test evolve faster than cancer.

Michael Churchill Image

Advances In Patient Tumoroid Screening

Friday, 5 October 2018 at 16:00

Add to Calendar ▼2018-10-05 16:00:002018-10-05 17:00:00Europe/LondonAdvances In Patient Tumoroid Screening3D-Culture and Organoids in Coronado Island, CaliforniaCoronado Island,

Ex-vivo organoid testing provides a 100-arm clinical trial for colorectal cancer patients.  The results of this trial have been used to improve patient outcomes beyond that offered by the current standard of care.

Add to Calendar ▼2018-10-04 00:00:002018-10-05 00:00:00Europe/London3D-Culture and Organoids3D-Culture and Organoids in Coronado Island, CaliforniaCoronado Island,